Research and experimental development on natural sciences and engineering
SPERMVITAL AS
Revenue 2024
NOK 23.9m
Operating profit
NOK 2.5m
Equity
NOK 9.6m
Incorporated
2008
Employees
11
Share capital
NOK 264,000
Roles
Daglig lederThor Arne Sletmoen
Revisor
Styrets lederKristin Malonæs
StyremedlemEven Søfteland
StyremedlemJon Rasmus Lang-Ree
StyremedlemHans Storlien
VaramedlemLars Skramstad
Auditor
Audit firm
TELL NORGE AS
TELL NORGE AS har 88 registrerte statsautoriserte revisorer.
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Auditor at related companies
3 of 3 companies in the same group use the same auditor.
| Company | Auditor | |
|---|---|---|
| GENO GLOBAL AS | TELL NORGE AS | same |
| GENO R&D AS | TELL NORGE AS | same |
| SPERMVITAL INVEST AS | TELL NORGE AS | same |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| GENO SA | 87.8% | 11578.000000 | 2025 |
| SPERMVITAL INVEST AS | 12.2% | 1602.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.